These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2155644)

  • 1. Phase II study of lonidamine in non-small cell lung cancer: final report.
    Kokron O; Maca S; De Gregorio M; Ciottoli GB
    Br J Cancer; 1990 Feb; 61(2):316-8. PubMed ID: 2155644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic administration of lonidamine in untreated non-small cell lung cancer of stage III M0-1.
    Scagliotti GV; Gozzelino F; Albera C; Pescetti G
    Chemotherapy; 1989; 35(1):64-8. PubMed ID: 2541978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised trial of MACC chemotherapy with or without lonidamine in advanced non-small cell lung cancer. Cuneo Lung Cancer Study Group (CuLCaSG).
    Buccheri G; Ferrigno D
    Eur J Cancer; 1994; 30A(10):1424-31. PubMed ID: 7833096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of lonidamine in inoperable non-small-cell lung cancer.
    Kokron O; Maca S; Scheiner W; De Gregorio M; Ciottoli GB
    Oncology; 1984; 41 Suppl 1():86-9. PubMed ID: 6717902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II double-blind randomized study of lonidamine and radiotherapy in epidermoid carcinoma of the lung.
    Privitera G; Ciottoli GB; Patanè C; Palmucci T; Tafuri G; Marletta F; De Luca B; Magnani F; De Gregorio M; Greco S
    Radiother Oncol; 1987 Dec; 10(4):285-90. PubMed ID: 3444905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lonidamine in non-small-cell lung cancer: a phase II study.
    Contu A; Olmeo NA; Pani P; Deriu A; Ortu S; Paga C
    Tumori; 1991 Feb; 77(1):52-5. PubMed ID: 1850177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lonidamine versus polychemotherapy in advanced non-small-cell lung cancer. A preliminary analysis.
    Giaccone G; Bagatella M; Donadio M; Bonardi G; Maestroni F; Calciati A
    Tumori; 1989 Feb; 75(1):43-6. PubMed ID: 2540581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of lonidamine in patients with small cell carcinoma of the lung.
    Murray N; Shah A; Band P
    Cancer Treat Rep; 1987 Dec; 71(12):1283-4. PubMed ID: 2825992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results.
    Chang AY; Kim K; Glick J; Anderson T; Karp D; Johnson D
    J Natl Cancer Inst; 1993 Mar; 85(5):388-94. PubMed ID: 8094467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lonidamine plus cyclophosphamide in the treatment of adanced non-small cell lung cancer in the elderly: a phase II study.
    Salvati F; Antilli A; Cruciani AR; Lombardi A; Mugnaini L; Nunziati F; Perrone N; Portalone L; Signora M
    Tumori; 1995; 81(1):48-51. PubMed ID: 7754542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin, epirubicin, and vindesine with or without lonidamine in the treatment of inoperable nonsmall cell lung carcinoma: a multicenter randomized clinical trial.
    Ianniello GP; De Cataldis G; Comella P; Scarpati MD; Maiorino A; Brancaccio L; Cioffi R; Lombardi A; Carnicelli P; Tinessa V
    Cancer; 1996 Jul; 78(1):63-9. PubMed ID: 8646728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III trial with and without lonidamine in non-small cell lung cancer.
    Gatzemeier U; Cavalli F; Häussinger K; Kaukel E; Koschel G; Martinelli G; Neuhauss R; von Pawel J
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):42-8. PubMed ID: 1851577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomized comparison of radiation therapy plus lonidamine versus radiation therapy plus placebo as initial treatment of clinically localized but nonresectable nonsmall cell lung cancer.
    Scarantino CW; McCunniff AJ; Evans G; Young CW; Paggiarino DA
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):999-1004. PubMed ID: 8083102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lonidamine alone and in combination with other chemotherapeutic agents in the treatment of cancer patients.
    Pacilio G; Carteni G; Biglietto M; De Cesare M
    Oncology; 1984; 41 Suppl 1():108-12. PubMed ID: 6326014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of lonidamine in metastatic breast cancer.
    Pronzato P; Amoroso D; Bertelli G; Conte PF; Cusimano MP; Ciottoli GB; Gulisano M; Lionetto R; Rosso R
    Br J Cancer; 1989 Feb; 59(2):251-3. PubMed ID: 2930690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study.
    Band PR; Maroun J; Pritchard K; Stewart D; Coppin CM; Wilson K; Eisenhauer EA
    Cancer Treat Rep; 1986 Nov; 70(11):1305-10. PubMed ID: 3768873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lonidamine in advanced colorectal cancer: a phase II study of the Italian Oncology Group for Clinical Research (GOIRC).
    Passalacqua R; Bisagni G; Bertusi M; Donati D; Buzzi F; Di Costanzo F; Basurto C; Gori S
    Tumori; 1989 Jun; 75(3):277-9. PubMed ID: 2672481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-agent gefitinib in patients with untreated advanced non-small-cell lung cancer and poor performance status: a Minnie Pearl Cancer Research Network Phase II Trial.
    Spigel DR; Hainsworth JD; Burkett ER; Burris HA; Yardley DA; Thomas M; Jones SF; Dickson NR; Scullin DC; Bradof JE; Rubinsak JR; Brierre JE; Greco FA
    Clin Lung Cancer; 2005 Sep; 7(2):127-32. PubMed ID: 16179100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II studies with carboplatin in non-small cell lung cancer.
    Gatzemeier U; Heckmayr M; Neuhauss R; Hossfeld D; Achterrath W; Lenaz L
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):25-31. PubMed ID: 2154856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of lonidamine in patients with metastatic renal cell carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study.
    Weinerman BH; Eisenhauer EA; Besner JG; Coppin CM; Stewart D; Band PR
    Cancer Treat Rep; 1986 Jun; 70(6):751-4. PubMed ID: 3524824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.